Applications invited for the following posts to the ICMR sanctioned clinical trial titled A phase III, multi center, randomized, double blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of single dose of dengue tetravalent vaccine, live attenuated (Recombinant, Lyophilized) DengiAll to Dr. Anil S Bilimale, Associate Professor, School of Public Health, JSS AHER
19-06-2026 to 30-06-2026